X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-04-18 | PHR | Gunzburg Janet | Principal Accounting Officer | S - Sale | $22.85 | -912 | 35,220 | -3% | -$20,836 | ||||||
2024-04-18 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $22.85 | -269 | 211,125 | 0% | -$6,146 | ||||||
2024-04-15 | PHR | Vanduyn Amy Beth | SVP, HR | S - Sale | $22.86 | -685 | 119,010 | -1% | -$15,657 | ||||||
2024-04-15 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $22.86 | -2,212 | 211,394 | -1% | -$50,561 | ||||||
2024-04-15 | PHR | Roberts Evan | COO | S - Sale | $22.86 | -2,029 | 754,903 | 0% | -$46,378 | ||||||
2024-04-15 | PHR | Hoffman Allison C | GC, Secretary | S - Sale | $22.86 | -1,238 | 135,621 | -1% | -$28,297 | ||||||
2024-04-15 | PHR | Gandhi Balaji | CFO | S - Sale | $22.86 | -948 | 97,230 | -1% | -$21,669 | ||||||
2024-04-15 | PHR | Indig Chaim | CEO | S - Sale | $22.86 | -3,392 | 1,477,005 | 0% | -$77,532 | ||||||
2024-04-10 | PHR | Gunzburg Janet | Principal Accounting Officer | S - Sale | $23.10 | -2,768 | 36,132 | -7% | -$63,928 | ||||||
| M | 2024-04-08 | PHR | Hoffman Allison C | GC, Secretary | S - Sale | $22.99 | -10,175 | 136,859 | -7% | -$233,879 | |||||
2024-04-08 | PHR | Gandhi Balaji | CFO | S - Sale | $22.62 | -7,778 | 98,178 | -7% | -$175,939 | ||||||
2024-04-08 | PHR | Indig Chaim | CEO | S - Sale | $22.62 | -12,043 | 1,480,397 | -1% | -$272,414 | ||||||
| M | 2024-04-08 | PHR | Vanduyn Amy Beth | SVP, HR | S - Sale | $23.05 | -7,122 | 119,695 | -6% | -$164,145 | |||||
| D | 2024-04-08 | PHR | Roberts Evan | COO | S - Sale+OE | $22.62 | -7,178 | 756,932 | -1% | -$162,367 | |||||
2024-04-08 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $22.62 | -4,161 | 213,606 | -2% | -$94,122 | ||||||
| M | 2024-03-19 | PHR | Gunzburg Janet | Principal Accounting Officer | S - Sale | $23.03 | -4,526 | 38,900 | -10% | -$104,219 | |||||
2024-03-25 | PHR | Gandhi Balaji | CFO | S - Sale | $23.21 | -3,504 | 94,030 | -4% | -$81,332 | ||||||
2024-03-21 | PHR | Roberts Evan | COO | S - Sale | $23.52 | -25,962 | 728,570 | -3% | -$610,684 | ||||||
2024-03-20 | PHR | Gunzburg Janet | Principal Accounting Officer | S - Sale | $23.66 | -137 | 38,949 | 0% | -$3,241 | ||||||
2024-03-20 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $23.66 | -30 | 211,154 | 0% | -$710 | ||||||
| M | 2024-03-18 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $23.16 | -448 | 211,184 | 0% | -$10,378 | |||||
2024-02-09 | PHR | Gunzburg Janet | Principal Accounting Officer | S - Sale | $28.00 | -480 | 39,086 | -1% | -$13,440 | ||||||
2024-02-02 | PHR | Gunzburg Janet | Principal Accounting Officer | S - Sale | $27.00 | -480 | 39,566 | -1% | -$12,960 | ||||||
| M | 2024-01-12 | PHR | Gunzburg Janet | Principal Accounting Officer | S - Sale | $25.27 | -533 | 40,046 | -1% | -$13,467 | |||||
| M | 2024-01-16 | PHR | Gandhi Balaji | CFO | S - Sale | $24.16 | -10,124 | 97,534 | -9% | -$244,602 | |||||
| M | 2024-01-16 | PHR | Vanduyn Amy Beth | SVP, HR | S - Sale | $24.15 | -10,951 | 119,695 | -8% | -$264,468 | |||||
| M | 2024-01-16 | PHR | Davidoff Michael J. | SVP, Payer Business | S - Sale | $24.15 | -18,987 | 73,391 | -21% | -$458,552 | |||||
| M | 2024-01-16 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $24.15 | -32,977 | 211,632 | -13% | -$796,441 | |||||
| M | 2024-01-16 | PHR | Hoffman Allison C | GC, Secretary | S - Sale | $24.18 | -8,921 | 136,859 | -6% | -$215,747 | |||||
| M | 2024-01-16 | PHR | Roberts Evan | COO | S - Sale | $24.14 | -43,328 | 754,532 | -5% | -$1,046,093 | |||||
| M | 2024-01-16 | PHR | Indig Chaim | CEO | S - Sale | $24.14 | -67,517 | 1,471,479 | -4% | -$1,630,138 | |||||
2023-12-19 | PHR | Gunzburg Janet | Principal Accounting Officer | S - Sale | $23.72 | -118 | 40,579 | 0% | -$2,799 | ||||||
| M | 2023-12-18 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $23.21 | -259 | 222,609 | 0% | -$6,011 | |||||
2023-11-01 | PHR | Gunzburg Janet | Principal Accounting Officer | S - Sale | $13.38 | -298 | 40,697 | -1% | -$3,988 | ||||||
2023-10-16 | PHR | Davidoff Michael J. | SVP, Payer Business | S - Sale | $16.61 | -1,198 | 92,378 | -1% | -$19,898 | ||||||
2023-10-16 | PHR | Gandhi Balaji | CFO | S - Sale | $16.61 | -861 | 85,658 | -1% | -$14,300 | ||||||
2023-10-16 | PHR | Vanduyn Amy Beth | SVP, HR | S - Sale | $16.61 | -665 | 118,146 | -1% | -$11,045 | ||||||
2023-10-16 | PHR | Hoffman Allison C | GC, Secretary | S - Sale | $16.61 | -1,297 | 115,025 | -1% | -$21,542 | ||||||
2023-10-16 | PHR | Roberts Evan | COO | S - Sale | $16.61 | -1,971 | 745,860 | 0% | -$32,736 | ||||||
2023-10-16 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $16.61 | -2,078 | 222,868 | -1% | -$34,514 | ||||||
2023-10-16 | PHR | Indig Chaim | CEO | S - Sale | $16.61 | -3,295 | 1,496,996 | 0% | -$54,727 | ||||||
2023-09-18 | PHR | Gunzburg Janet | Principal Accounting Officer | S - Sale | $19.79 | -125 | 40,995 | 0% | -$2,474 | ||||||
2023-09-18 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $19.67 | -130 | 224,946 | 0% | -$2,557 | ||||||
2023-09-13 | PHR | Roberts Evan | COO | S - Sale | $20.34 | -3,907 | 747,831 | -1% | -$79,465 | ||||||
| M | 2023-09-13 | PHR | Hoffman Allison C | GC, Secretary | S - Sale | $20.27 | -5,466 | 116,322 | -4% | -$110,790 | |||||
| M | 2023-09-13 | PHR | Vanduyn Amy Beth | SVP, HR | S - Sale | $20.24 | -3,826 | 118,811 | -3% | -$77,455 | |||||
2023-09-13 | PHR | Gunzburg Janet | Principal Accounting Officer | S - Sale | $20.34 | -934 | 41,120 | -2% | -$18,996 | ||||||
2023-09-13 | PHR | Gandhi Balaji | CFO | S - Sale | $20.34 | -3,957 | 86,519 | -4% | -$80,482 | ||||||
| M | 2023-09-13 | PHR | Davidoff Michael J. | SVP, Payer Business | S - Sale | $20.26 | -6,559 | 93,576 | -7% | -$132,880 | |||||
2023-09-13 | PHR | Indig Chaim | CEO | S - Sale | $20.34 | -6,555 | 1,500,291 | 0% | -$133,323 | ||||||
| D | 2023-09-13 | PHR | Linetsky David | SVP, Life Sciences | S - Sale+OE | $20.34 | -2,178 | 225,076 | -1% | -$44,299 | |||||
2023-07-21 | PHR | Davidoff Michael J. | SVP, Payer Business | S - Sale | $31.75 | -1,075 | 93,576 | -1% | -$34,131 | ||||||
2023-05-10 | PHR | Munson Gillian | Dir | S - Sale | $30.06 | -3,555 | 19,315 | -16% | -$106,864 | ||||||
2023-04-21 | PHR | Davidoff Michael J. | SVP, Payer Business | S - Sale | $33.13 | -1,075 | 95,773 | -1% | -$35,615 | ||||||
2023-04-18 | PHR | Roberts Evan | COO | S - Sale | $32.09 | -7,452 | 716,960 | -1% | -$239,167 | ||||||
| D | 2023-04-17 | PHR | Vanduyn Amy Beth | SVP, HR | S - Sale+OE | $31.84 | -570 | 119,435 | 0% | -$18,149 | |||||
2023-04-17 | PHR | Gandhi Balaji | CFO | S - Sale | $31.83 | -2,113 | 85,738 | -2% | -$67,248 | ||||||
2023-04-17 | PHR | Roberts Evan | COO | S - Sale | $32.01 | -2,600 | 724,412 | 0% | -$83,229 | ||||||
2023-04-14 | PHR | Hoffman Allison C | GC, Secretary | S - Sale | $31.16 | -3,306 | 128,335 | -3% | -$103,017 | ||||||
2023-04-12 | PHR | Roberts Evan | COO | S - Sale | $32.01 | -200 | 728,793 | 0% | -$6,402 | ||||||
2023-04-11 | PHR | Davidoff Michael J. | SVP, Payer Business | S - Sale | $30.91 | -3,466 | 97,971 | -3% | -$107,124 | ||||||
2023-04-03 | PHR | Vanduyn Amy Beth | SVP, HR | S - Sale | $30.79 | -2,978 | 96,481 | -3% | -$91,697 | ||||||
| D | 2023-04-03 | PHR | Smith Mark Douglas | Dir | S - Sale+OE | $30.77 | -7,000 | 16,112 | -30% | -$215,367 | |||||
2023-02-02 | PHR | Rasmussen Randy | CFO | S - Sale | $40.00 | -4,765 | 145,594 | -3% | -$190,600 | ||||||
2023-02-02 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $39.55 | -11,378 | 211,072 | -5% | -$449,989 | ||||||
2023-02-02 | PHR | Vanduyn Amy Beth | SVP, HR | S - Sale | $40.00 | -300 | 99,459 | 0% | -$12,000 | ||||||
2023-02-02 | PHR | Davidoff Michael J. | SVP, Payer Business | S - Sale | $39.21 | -7,513 | 97,971 | -7% | -$294,564 | ||||||
| DM | 2023-01-30 | PHR | Davidoff Michael J. | SVP, Payer Business | S - Sale+OE | $36.29 | -31,820 | 105,484 | -23% | -$1,154,872 | |||||
2023-01-18 | PHR | Hoffman Allison C | GC, Secretary | S - Sale | $36.07 | -649 | 129,507 | 0% | -$23,407 | ||||||
2023-01-03 | PHR | Roberts Evan | COO | S - Sale | $31.36 | -10,000 | 703,702 | -1% | -$313,552 | ||||||
| D | 2022-12-20 | PHR | Vanduyn Amy Beth | SVP, HR | S - Sale+OE | $33.73 | -378 | 87,049 | 0% | -$12,750 | |||||
| M | 2022-12-13 | PHR | Hoffman Allison C | GC, Secretary | S - Sale | $34.73 | -3,910 | 102,262 | -4% | -$135,786 | |||||
2022-12-13 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $34.61 | -11,377 | 191,119 | -6% | -$393,755 | ||||||
2022-12-09 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $29.78 | -26,837 | 202,496 | -12% | -$799,072 | ||||||
| M | 2022-12-09 | PHR | Rasmussen Randy | CFO | S - Sale | $30.97 | -17,329 | 108,539 | -14% | -$536,765 | |||||
2022-11-02 | PHR | Vanduyn Amy Beth | SVP, HR | S - Sale | $26.83 | -19,341 | 72,427 | -21% | -$518,958 | ||||||
2022-10-18 | PHR | Davidoff Michael J. | SVP, Payer Business | S - Sale | $25.26 | -1,075 | 106,114 | -1% | -$27,155 | ||||||
2022-09-16 | PHR | Davidoff Michael J. | SVP, Payer Business | S - Sale | $27.60 | -1,296 | 108,312 | -1% | -$35,773 | ||||||
2022-09-15 | PHR | Hoffman Allison C | GC, Secretary | S - Sale | $28.58 | -1,290 | 107,300 | -1% | -$36,866 | ||||||
2022-07-21 | PHR | Davidoff Michael J. | SVP, Payer Business | S - Sale | $25.00 | -1,404 | 108,312 | -1% | -$35,100 | ||||||
2022-07-11 | PHR | Munson Gillian | Dir | S - Sale | $25.59 | -2,605 | 21,550 | -11% | -$66,656 | ||||||
2022-06-24 | PHR | Davidoff Michael J. | SVP, Payer Business | S - Sale | $25.11 | -5,046 | 110,509 | -4% | -$126,705 | ||||||
2022-05-16 | PHR | Munson Gillian | Dir | S - Sale | $16.06 | -2,106 | 16,758 | -11% | -$33,815 | ||||||
2022-05-09 | PHR | Hoffman Allison C | GC, Secretary | S - Sale | $17.07 | -3,909 | 115,099 | -3% | -$66,708 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |